Lenalid Capsule (Lenalidomide): Immunomodulatory Antineoplastic Oral Therapy | For Multiple Myeloma, Myelodysplastic Syndromes & Hematologic Malignancy Management
Lenalid Capsule, also known by its generic name Lenalidomide/Revlimid, is a medication that belongs to a class of drugs called immunomodulatory agents. It is primarily used in the treatment of certain types of cancers, such as multiple myeloma and myelodysplastic syndromes (MDS).
Product Overview
Lenalid Capsule contains lenalidomide, an immunomodulatory medicine used in the treatment of certain blood cancers and bone marrow disorders. It is commonly used for multiple myeloma and selected cases of myelodysplastic syndromes. Depending on the diagnosis and treatment plan, it may be used alone or alongside other medicines.
Composition and Formulation
The active ingredient in Lenalid Capsule is lenalidomide. It is an oral medicine available in different strengths, so the exact strength should be confirmed from the product packaging. The dose and schedule are determined by the specialist according to the condition being treated and the individual's health status.
How Lenalid Capsule Works
Lenalidomide affects immune system activity and interferes with the growth and survival of certain abnormal cells. It can also influence the bone marrow environment and support immune responses that help the body manage abnormal cell growth.
Role in Multiple Myeloma
Multiple myeloma is a type of blood cancer involving plasma cells in the bone marrow. Lenalidomide is used in specific treatment regimens to help control abnormal plasma cell growth. The treatment plan may include other medicines depending on the stage of the condition, previous treatment, and individual response.
Role in Myelodysplastic Syndromes
Lenalidomide may be used for selected people with myelodysplastic syndromes, a group of bone marrow disorders in which blood cells do not develop normally. In particular, it has a role in certain cases associated with a specific chromosome 5 abnormality. The suitability of treatment depends on clinical assessment and relevant test results.
Oral Administration and Treatment Schedule
Lenalid Capsule is taken by mouth according to the treatment schedule provided by the specialist. Depending on the prescribed regimen, treatment may involve specific days of a treatment cycle followed by a rest period. The capsule should be handled and taken according to the product instructions.
Individualized Treatment and Monitoring
The dose of lenalidomide may depend on kidney function, blood cell counts, the condition being treated, and other medicines used in the treatment plan. Regular blood tests and follow-up appointments help the healthcare team assess treatment response and determine whether any adjustments are needed.
Summary
Lenalid Capsule contains lenalidomide, an immunomodulatory medicine used for selected blood cancers and bone marrow disorders. It works by modifying immune activity and affecting abnormal cell growth. Its use requires an individualized treatment plan, appropriate monitoring, and guidance from a qualified specialist.
Some of the Key Safety Advice for Lenalid Capsule (Lenalidomide)
Pregnancy: Lenalidomide can cause severe birth defects and should not be used during pregnancy. It is essential to use effective contraception during treatment with Lenalidomide and for at least four weeks before starting treatment, during treatment, and for at least four weeks after stopping treatment.
Blood Clotting: Lenalidomide/Revlimid increases the risk of blood clots, including deep vein thrombosis (DVT) and pulmonary embolism (PE). Patients with a history of blood clots or those at increased risk should be closely monitored, and preventive measures may be taken, such as the use of blood-thinning medications.
Hematologic Toxicity: Lenalidomide can suppress bone marrow function, leading to decreased production of blood cells. Regular blood tests should be conducted to monitor blood counts, including white blood cells, red blood cells, and platelets. Dose adjustments or interruptions may be necessary if significant cytopenias develop.
Hepatotoxicity: Lenalidomide can cause liver toxicity. Liver function tests should be performed regularly, and any signs of liver dysfunction, such as jaundice or elevated liver enzymes, should be promptly reported to the healthcare provider.
Tumor Flare Reaction: In some cases, Lenalidomide can cause an initial worsening of symptoms or an increase in tumor size before improvement occurs. This reaction is known as a tumor flare reaction and should be closely monitored by the healthcare provider.
Renal Impairment: Patients with pre-existing renal impairment may require dosage adjustments or close monitoring while taking Lenalidomide. Renal function should be assessed before initiating treatment and regularly during therapy.
Primary Application To Be Notice for Lenalid Capsule (Lenalidomide)
Lenalidomide is primarily used in the treatment of multiple myeloma, cancer that affects plasma cells in the bone marrow. It is often prescribed in combination with other medications, such as dexamethasone, for the management of multiple myeloma. As Anti-Cancer Drug, Additionally, Lenalidomide is used to treat myelodysplastic syndromes (MDS), a group of blood disorders characterized by ineffective production of blood cells. It has also shown efficacy in the treatment of mantle cell lymphoma (MCL) in patients who have received prior therapy.
Common Secondary Effects of Lenalid Capsule (Lenalidomide)
Hematologic Effects: Lenalidomide can cause a decrease in the number of blood cells, including white blood cells, red blood cells, and platelets. This may increase the risk of infections, anemia, and bleeding.
Gastrointestinal Effects: Common gastrointestinal side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain. These symptoms can usually be managed with supportive care and medications.
Fatigue: Fatigue is a common side effect of Lenalidomide treatment. It is important to balance activity and rest and to communicate any persistent fatigue to the healthcare provider.
Skin Reactions: Rash and skin reactions, such as itching and dryness, may occur with Lenalidomide treatment. It is advisable to avoid excessive sun exposure and to use sunscreen and protective clothing.
Peripheral Neuropathy: Lenalidomide can cause peripheral neuropathy, characterized by tingling, numbness, or pain in the hands and feet. Patients experiencing these symptoms should inform their healthcare provider.
Cardiovascular Effects: Lenalidomide may increase the risk of cardiovascular events, such as heart attack and stroke, particularly in patients with pre-existing cardiovascular conditions. Regular monitoring of cardiovascular health is recommended during treatment.
Concerns You May Have While Using Lenalid Capsule (Lenalidomide)
Can Lenalidomide be used as a standalone treatment for multiple myeloma?
Lenalidomide is typically not used as a standalone treatment for multiple myeloma. It is commonly prescribed in combination with other medications, such as dexamethasone, to enhance its effectiveness in managing the disease.
Is Lenalidomide suitable for all patients with multiple myeloma?
Lenalidomide treatment is prescribed based on individual patient factors, including the stage and characteristics of the disease. It may not be suitable for all patients, and the decision to use Lenalidomide is made by the healthcare provider after assessing the specific patient's condition.
Can Lenalidomide be used in patients with pre-existing liver disease?
Lenalidomide can cause hepatotoxicity; therefore, patients with pre-existing liver disease should be closely monitored and the use of Lenalidomide should be determined on a case-by-case basis. Liver function tests should be conducted regularly during treatment.
Are there any specific dietary restrictions while taking Lenalidomide?
There are no specific dietary restrictions associated with Lenalidomide. However, it is important to maintain a balanced diet and stay well-hydrated during treatment to support overall health and manage potential gastrointestinal side effects.
Can Lenalidomide interact with herbal supplements or over-the-counter medications?
Lenalidomide has the potential to interact with herbal supplements and over-the-counter medications. It is important to inform the healthcare provider about all medications, including herbal supplements and over-the-counter drugs, being taken concurrently to ensure there are no potential interactions that may affect the safety or effectiveness of Lenalidomide treatment.
Some Common Drug Connections with Lenalid Capsule (Lenalidomide)
Warfarin: Lenalidomide may enhance the anticoagulant effects of warfarin, increasing the risk of bleeding. Close monitoring of blood clotting parameters is necessary when these drugs are used concomitantly.
Strong CYP3A4 Inducers/Inhibitors: Drugs that induce or inhibit the CYP3A4 enzyme system can affect the metabolism and efficacy of Lenalidomide. The dose of Lenalidomide may need to be adjusted when used with these drugs.
Digoxin: Lenalidomide/Revlimid may increase the serum concentration of digoxin, leading to potential toxicity. Regular monitoring of digoxin levels and appropriate dose adjustments are recommended when these medications are used together.
Vaccines: Live vaccines should be avoided while receiving Lenalidomide due to the potential for decreased immune response. Inactivated vaccines may be less effective during treatment. It is advisable to consult with the healthcare provider regarding appropriate vaccination schedules.
| Manufacturer | : | Natco Pharma, India |
| Equivalent Brand | : | Revlimid |
| Generic Search | : | Lenalidomide |
Latest Products
